RIGL   $13.665  0.26% Market Closed After Close 13.69 0.18%

Rigel Pharmaceuticals Inc
Total Cash 49.10M
totalCashPerShare 2.791
EBITDA -7.52M
Total Debt 100.31M
quickRatio 1.33
currentRatio 1.615
Total Revenue 130.20M
debtToEquity
Revenue/Share 7.446
ROA -0.046430003
ROE
grossProfits
freeCashflow 11.18M
operatingCashflow -12.31M
earningsGrowth
revenueGrowth 0.423
grossMargins 0.76101
ebitdaMargins -0.05776
operatingMargins 0.012130001
profitMargins -0.10931
enterpriseValue 292.26M
forwardPE 21.40625
floatShares 14.73M
sharesOutstanding 17.59M
sharesShort 585.29K
sharesShortPriorMonth 552.13K
dateShortInterest
sharesPercentSharesOut 0.03%
heldPercentInsiders 0.02%
heldPercentInstitutions 0.60%
Short Ratio help_outline 5.40%
shortPercentOfFloat 0.03%
impliedSharesOutstanding
bookValue -1.7
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -14.23M
trailingEps -0.77%
forwardEps 0.64%
enterpriseToEbitda -38.87
lastDividendValue
lastDividendDate
currentQuarterEstimate 0.06 3Q 2024
institutionsCount 130
lastUpdated Sept. 16, 2024, 11:25 a.m.